Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:605077's PB Ratio is ranked better than 71.03% of 1574
companies
in the Chemicals industry
Industry Median: 1.61
vs SHSE:605077: 1.01
During the past 12 months, Zhejiang Huakang Pharmaceutical Co's average Book Value Per Share Growth Rate was -0.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 17.20% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Zhejiang Huakang Pharmaceutical Co was 62.90% per year. The lowest was 6.10% per year. And the median was 42.80% per year.
Back to Basics: PB Ratio
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Zhejiang Huakang Pharmaceutical Co PB Ratio Related Terms
Zhejiang Huakang Pharmaceutical Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Zhejiang Huakang Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Huakang Pharmaceutical Co PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Zhejiang Huakang Pharmaceutical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zhejiang Huakang Pharmaceutical Co's PB Ratio falls into.
Zhejiang Huakang Pharmaceutical Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) has a PB Ratio of 1.01 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. This is 46% below median its historical median of 1.87. Over the past decade, Zhejiang Huakang Pharmaceutical Co's PB Ratio has ranged from 0.93 to 9.21. According to the industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #456 out of 1574 companies in the Chemicals industry, placing it in the top 29%.
Is Zhejiang Huakang Pharmaceutical Co's PB Ratio too high?
Zhejiang Huakang Pharmaceutical Co's current PB Ratio of 1.01 is 46% below median its 10-year median of 1.87. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 9.21. The Chemicals industry median PB Ratio is 1.61. Zhejiang Huakang Pharmaceutical Co's value of 1.01 is 37.3% below this industry median. Based on the distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #456 out of 1574 companies in the Chemicals industry, which is above the industry midpoint. Overall, Zhejiang Huakang Pharmaceutical Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Huakang Pharmaceutical Co's PB Ratio compare to DOW?
According to the Chemicals industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #456 out of 1574 companies for PB Ratio. This puts Zhejiang Huakang Pharmaceutical Co in the upper half of its industry. The industry median PB Ratio is 1.61. Zhejiang Huakang Pharmaceutical Co's value of 1.01 is 37.3% below this benchmark. Historically, Zhejiang Huakang Pharmaceutical Co's own PB Ratio has ranged from 0.93 to 9.21 over the past decade. While the company's 10-year median is 1.87 vs. the industry median of 1.61, Zhejiang Huakang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.61, based on 1,574 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Huakang Pharmaceutical Co's current PB Ratio of 1.01 is 37.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. For the Chemicals industry, the median PB Ratio is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Huakang Pharmaceutical Co's current PB Ratio is 1.01, which is 46% below median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Huakang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co (SHSE:605077) is currently considered Possible Value Trap. The stock's GF Value™ is ¥39.70, compared to a current price of ¥10.90 — trading 72.5% below its estimated fair value. The current PB Ratio is 1.01, which is 46% below median its 10-year median of 1.87 and 37.3% below the Chemicals industry median of 1.61. Zhejiang Huakang Pharmaceutical Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Zhejiang Huakang Pharmaceutical Co (SHSE:605077), the current PB Ratio is 1.01 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥10.90 is trading 72.5% below its estimated GF Value™ of ¥39.70.
GuruFocus considers Zhejiang Huakang Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for SHSE:605077:
PB Ratio: 1.01 (46% below median its 10-year median of 1.87)
GF Value™: ¥39.70 vs. price of ¥10.90 (72.5% below fair value)
Industry Position: 37.3% below the Chemicals median (#456 of 1574)
No single metric tells the full story. See the SHSE:605077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Huakang Pharmaceutical Co Business Description
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
74GF Score
Get the complete analysis for SHSE:605077
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605077 has been successfully added to your 
